Role of myoepithelial cells in breast tumor progression.
暂无分享,去创建一个
[1] T. Murrell. The potential for oxytocin (OT) to prevent breast cancer: a hypothesis , 1995, Breast Cancer Research and Treatment.
[2] J. Smith,et al. Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells. , 1986, The American journal of pathology.
[3] S. Taniguchi,et al. The induction of smooth muscle alpha actin in a transformed rat cell line suppresses malignant properties in vitro and in vivo. , 1999, Cancer letters.
[4] George Reid,et al. Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines , 1999, Oncogene.
[5] E. Masini,et al. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. , 1995, Cancer research.
[6] S. Groshen,et al. Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. , 1997, Journal of the National Cancer Institute.
[7] L. Liotta,et al. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.
[8] Kornelia Polyak,et al. Do Myoepithelial Cells Hold the Key for Breast Tumor Progression? , 2005, Journal of Mammary Gland Biology and Neoplasia.
[9] D. Danila,et al. Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling. , 2000, Molecular endocrinology.
[10] E. Kubista,et al. MMP-2 and MMP-9 Expression in Breast Cancer-Derived Human Fibroblasts is Differentially Regulated by Stromal-Epithelial Interactions , 2002, Breast Cancer Research and Treatment.
[11] D. Wong,et al. The Tumor Suppressor Maspin Does Not Undergo the Stressed to Relaxed Transition or Inhibit Trypsin-like Serine Proteases. , 1995, The Journal of Biological Chemistry.
[12] S. Masood,et al. Application of immunostaining for muscle specific actin in detection of myoepithelial cells in breast fine‐needle aspirates , 1995, Diagnostic cytopathology.
[13] S. Barsky,et al. Myoepithelial Cells: Autocrine and Paracrine Suppressors of Breast Cancer Progression , 2005, Journal of Mammary Gland Biology and Neoplasia.
[14] L. Akslen,et al. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Allen M. Gown,et al. Differential Expression of Myoepithelial Markers in Salivary, Sweat and Mammary Glands , 2000, International journal of surgical pathology.
[16] S. Barsky,et al. The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype , 2000, Oncogene.
[17] J. Tobacman. Filament disassembly and loss of mammary myoepithelial cells after exposure to lambda-carrageenan. , 1997, Cancer research.
[18] Robert A. Weinberg,et al. Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type , 2006, Cell cycle.
[19] L. Cutler. The Role of Extracellular Matrix in the Morphogenesis and Differentiation of Salivary Glands , 1990, Advances in dental research.
[20] J. Laissue,et al. MMP‐19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours , 2001, The Journal of pathology.
[21] John N. Hutchinson,et al. Caveolin-1 Gene Disruption Promotes Mammary Tumorigenesis and Dramatically Enhances Lung Metastasis in Vivo , 2004, Journal of Biological Chemistry.
[22] R. Cardone,et al. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis , 2005, Nature Reviews Cancer.
[23] J. Thiery,et al. The importance of being a myoepithelial cell , 2002, Breast Cancer Research.
[24] O. Petersen,et al. A function for filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts , 1996, The Journal of cell biology.
[25] S. Lydersen,et al. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast , 2004, Diagnostic cytopathology.
[26] Mina J Bissell,et al. Myoepithelial cells: good fences make good neighbors , 2005, Breast Cancer Research.
[27] Jan E Schnitzer,et al. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells , 1998, Oncogene.
[28] H. Cooper,et al. Mouse Neogenin, a DCC-like molecule, has four splice variants and is expressed widely in the adult mouse and during embryogenesis , 1997, Oncogene.
[29] L. Akslen,et al. Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients , 2006, International journal of cancer.
[30] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[31] L. Liotta,et al. Proteolytic Enzymes in Cancer Invasion and Metastasis , 1986, Seminars in thrombosis and hemostasis.
[32] J. Whisstock,et al. Function of maspin. , 1994, Science.
[33] Y. Man. Focal degeneration of aged or injured myoepithelial cells and the resultant auto-immunoreactions are trigger factors for breast tumor invasion. , 2007, Medical hypotheses.
[34] J. Ni,et al. Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Stacey,et al. Plasminogen activator inhibitors: hormonally regulated serpins , 1990, Molecular and Cellular Endocrinology.
[36] K. Brew,et al. Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.
[37] S. Barsky,et al. Myoepithelial-specific CD44 shedding contributes to the anti-invasive and antiangiogenic phenotype of myoepithelial cells. , 2000, Experimental cell research.
[38] S. Barsky,et al. The myoepithelial defense: a host defense against cancer. , 1997, Medical hypotheses.
[39] E. Lane,et al. Characterization in vitro of luminal and myoepithelial cells isolated from the human mammary gland by cell sorting. , 1991, Differentiation; research in biological diversity.
[40] G. Turashvili,et al. A novel myoepithelial/progenitor cell marker in the breast? , 2007, Virchows Archiv.
[41] Q. Sang,et al. The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis. , 2004, Experimental cell research.
[42] M. Hendrix,et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. , 1994, Science.
[43] A. Goel,et al. Role of proteases in tumor invasion and metastasis. , 1997, Indian journal of experimental biology.
[44] W. Han,et al. Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer , 2005, BMC Cancer.
[45] R. Hruban,et al. ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[46] E. Rofstad,et al. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. , 2006, Cancer research.
[47] S. Schnitt. The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin , 2009, Breast Cancer Research.
[48] A. Sapino,et al. Oxytocin enhances myoepithelial cell differentiation and proliferation in the mouse mammary gland. , 1993, Endocrinology.
[49] Yue Zhao,et al. Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. , 2008, Folia histochemica et cytobiologica.
[50] M. Herlyn,et al. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[51] P. Rudland. Stem cells and the development of mammary cancers in experimental rats and in humans , 2004, Cancer and Metastasis Reviews.
[52] K. Nabeshima,et al. Reverse‐zymographic analysis of protease nexin‐II/amyloid β protein precursor of human carcinoma cell lines, with special reference to the grade of differentiation and metastatic phenotype , 1995, International journal of cancer.
[53] S. Lakhani,et al. Myoepithelial Cells: Pathology, Cell Separation and Markers of Myoepithelial Differentiation , 2005, Journal of Mammary Gland Biology and Neoplasia.
[54] E. Rofstad. Microenvironment-induced cancer metastasis , 2000, International journal of radiation biology.
[55] Serge Lemay,et al. The p38 MAPK Pathway Is Required for Cell Growth Inhibition of Human Breast Cancer Cells in Response to Activin* , 2001, The Journal of Biological Chemistry.
[56] A. Gown,et al. Antibodies to Novel Myoepithelium-Associated Proteins Distinguish Benign Lesions and Carcinoma in Situ From Invasive Carcinoma of the Breast , 1997 .
[57] J. Shaw,et al. Primary breast myoepithelial cells exert an invasion‐suppressor effect on breast cancer cells via paracrine down‐regulation of MMP expression in fibroblasts and tumour cells , 2003, The Journal of pathology.
[58] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[59] Robin L. Anderson,et al. Caveolin-1 inhibits breast cancer growth and metastasis , 2004, Oncogene.
[60] P. Dey,et al. Myoepithelial Cells: Any role in aspiration cytology smears of breast tumors? , 2008, CytoJournal.
[61] Mina J Bissell,et al. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. , 2010, Journal of cell science.
[62] Qing Shao,et al. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. , 2006, Cancer research.
[63] M. Duffy,et al. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis , 2000, Breast Cancer Research.
[64] K. Cooper,et al. Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain , 2004, Journal of Clinical Pathology.